Valuation: Compumedics Limited

Market Cap 4.39Cr 3.04Cr 2.67Cr 2.5Cr 2.29Cr 4.29Cr 291.55Cr 30Cr 12Cr 144.27Cr 11Cr 11Cr 498.75Cr P/E 2026 *
14.7x
P/E 2027 * 5.95x
Enterprise Value 4.39Cr 3.04Cr 2.67Cr 2.5Cr 2.29Cr 4.29Cr 291.55Cr 30Cr 12Cr 144.27Cr 11Cr 11Cr 498.75Cr EV / Sales 2026 *
0.66x
EV / Sales 2027 * 0.55x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 9.09%
1 day-8.33%
1 week-4.35%
Current month-13.73%
1 month-12.00%
3 months-26.67%
6 months-48.84%
Current year-34.33%
1 week 0.22
Extreme 0.215
0.24
1 month 0.22
Extreme 0.215
0.3
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-8.33%-4.35%-27.87%+29.41% 3.04Cr
+0.01%+9.50%+19.56%+2.60% 21TCr
-1.29%+9.69%-5.01%-24.45% 14TCr
-2.40%+3.64%-28.94%+8.14% 12TCr
-0.04%+7.14%-56.76%-10.93% 6.84TCr
+2.49%+1.65%+6.57%+2.41% 4.94TCr
-0.75%+9.46%-24.73%-29.48% 4.76TCr
-0.17%+5.13%+17.07%+11.31% 3.96TCr
-1.15%+2.34%+25.16%+32.79% 3.73TCr
+2.55%+11.08%-22.83%-3.98% 3.09TCr
Average -0.92%+5.37%-9.78%+1.78% 7.5TCr
Weighted average by Cap. -0.50%+7.26%-5.25%-3.05%

Financials

2026 *2027 *
Net sales 6.63Cr 4.59Cr 4.04Cr 3.77Cr 3.46Cr 6.47Cr 439.84Cr 45Cr 17Cr 217.65Cr 17Cr 17Cr 752.42Cr 7.97Cr 5.52Cr 4.85Cr 4.53Cr 4.16Cr 7.78Cr 528.74Cr 54Cr 21Cr 261.64Cr 21Cr 20Cr 904.49Cr
Net income 38L 26.32L 23.13L 21.59L 19.81L 37.09L 25Cr 2.56Cr 1Cr 12Cr 98.82L 96.67L 43Cr 90L 62.34L 54.77L 51.13L 46.92L 87.83L 60Cr 6.06Cr 2.37Cr 30Cr 2.34Cr 2.29Cr 102.14Cr
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
29/26/29 A$0.2200 -8.33% 25,561
28/26/28 A$0.2400 0.00% 4,166
27/26/27 A$0.2400 +4.35% 5,000
22/26/22 A$0.2300 -6.12% 2,400
21/26/21 A$0.2450 +13.95% 9,802
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2200AUD
Average target price
0.8000AUD
Spread / Average Target
+263.64%

Annual profits - Rate of surprise